Year archive

Ascletis Pharma Inc. — 2024 filings

All 184 regulatory filings released by Ascletis Pharma Inc. (1672) in 2024, sourced directly from the official regulator.

184 Filings

2024 Period

2024 filings (184)

Filing	Released	Lang
Next Day Disclosure Return Transaction in Own Shares	2024-12-31	English
Next Day Disclosure Return Transaction in Own Shares	2024-12-30	English
Next Day Disclosure Return Transaction in Own Shares	2024-12-27	English
VOLUNTARY ANNOUNCEMENT INDUSTRIAL LAND REFORM PROPOSAL Regulatory Filings	2024-12-20	English
Next Day Disclosure Return Transaction in Own Shares	2024-12-20	English
Next Day Disclosure Return Transaction in Own Shares	2024-12-19	English
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES ASC47, A MUSCLE-PRESERVING WEIGHT LOSS DRUG CANDIDATE FOR TREATMENT OF OBESITY, IN COMBINATION WITH SEMAGLUTIDE, DEMONSTRATED SUPERIOR WEIGHT LOSS TO SEMAGL Regulatory Filings	2024-12-18	English
Next Day Disclosure Return Transaction in Own Shares	2024-12-13	English
Next Day Disclosure Return Transaction in Own Shares	2024-12-12	English
Next Day Disclosure Return Transaction in Own Shares	2024-12-11	English
Next Day Disclosure Return Transaction in Own Shares	2024-12-10	English
Next Day Disclosure Return Transaction in Own Shares	2024-12-09	English
Next Day Disclosure Return Transaction in Own Shares	2024-12-06	English
Next Day Disclosure Return Transaction in Own Shares	2024-12-05	English
Next Day Disclosure Return Transaction in Own Shares	2024-12-04	English
Next Day Disclosure Return Transaction in Own Shares	2024-12-03	English
CHANGE OF HONG KONG SHARE REGISTRAR AND TRANSFER OFFICE Regulatory Filings	2024-12-02	English
Monthly Return of Equity Issuer on movements in Securities for the month ended 30 November 2024 Regulatory Filings	2024-12-02	English
Next Day Disclosure Return Transaction in Own Shares	2024-12-02	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024 Regulatory Filings	2024-12-02	English
Next Day Disclosure Return Transaction in Own Shares	2024-11-27	English
Next Day Disclosure Return Transaction in Own Shares	2024-11-26	English
CLARIFICATION ANNOUNCEMENT GRANT OF SHARE OPTIONS Regulatory Filings	2024-11-25	English
Next Day Disclosure Return Regulatory Filings	2024-11-25	English
Next Day Disclosure Return Regulatory Filings	2024-11-22	English
Next Day Disclosure Return Regulatory Filings	2024-11-21	English
Next Day Disclosure Return Regulatory Filings	2024-11-20	English
GRANT OF SHARE OPTIONS Regulatory Filings	2024-11-19	English
Next Day Disclosure Return Regulatory Filings	2024-11-19	English
Next Day Disclosure Return Regulatory Filings	2024-11-18	English
Next Day Disclosure Return Regulatory Filings	2024-11-15	English
Next Day Disclosure Return Regulatory Filings	2024-11-14	English
Next Day Disclosure Return Regulatory Filings	2024-11-13	English
VOLUNTARY ANNOUNCEMENT - ASCLETIS COMPLETES ENROLLMENT OF PHASE III TRIAL OF ASC40 (DENIFANSTAT) ONCE-DAILY ORAL TABLET FOR TREATMENT OF ACNE Regulatory Filings	2024-11-12	English
Next Day Disclosure Return Regulatory Filings	2024-11-12	English
Next Day Disclosure Return Regulatory Filings	2024-11-11	English
Next Day Disclosure Return Regulatory Filings	2024-11-08	English
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES PROMISING RESULTS FROM A PHASE I STUDY IN AUSTRALIA FOR FIRST-IN-CLASS MUSCLE-PRESERVING WEIGHT LOSS DRUG CANDIDATE ASC47 FOR THE TREATMENT OF OBESITY Regulatory Filings	2024-11-07	English
Next Day Disclosure Return Regulatory Filings	2024-11-06	English
Next Day Disclosure Return Regulatory Filings	2024-11-05	English
Next Day Disclosure Return Regulatory Filings	2024-11-04	English
Monthly Return of Equity Issuer on movements in Securities for the month ended 31 October 2024 Regulatory Filings	2024-11-01	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024 Regulatory Filings	2024-11-01	English
Next Day Disclosure Return Regulatory Filings	2024-11-01	English
Next Day Disclosure Return Regulatory Filings	2024-10-31	English
Next Day Disclosure Return Regulatory Filings	2024-10-30	English
Next Day Disclosure Return Regulatory Filings	2024-10-29	English
Next Day Disclosure Return Regulatory Filings	2024-10-28	English
Next Day Disclosure Return Regulatory Filings	2024-10-25	English
Next Day Disclosure Return Regulatory Filings	2024-10-24	English
Next Day Disclosure Return Regulatory Filings	2024-10-23	English
Next Day Disclosure Return Regulatory Filings	2024-10-22	English
Next Day Disclosure Return Regulatory Filings	2024-10-21	English
Next Day Disclosure Return Regulatory Filings	2024-10-18	English
Next Day Disclosure Return Regulatory Filings	2024-10-17	English
Next Day Disclosure Return Regulatory Filings	2024-10-16	English
Next Day Disclosure Return Regulatory Filings	2024-10-15	English
Next Day Disclosure Return Regulatory Filings	2024-10-14	English
Next Day Disclosure Return Regulatory Filings	2024-10-10	English
Next Day Disclosure Return Regulatory Filings	2024-10-09	English
Next Day Disclosure Return Regulatory Filings	2024-10-08	English
Next Day Disclosure Return Regulatory Filings	2024-10-07	English
INSIDE INFORMATION - UPDATE ON LEGAL PROCEEDINGS INVOLVING ASC41 AND ASC43F Regulatory Filings	2024-10-07	English
Monthly Return of Equity Issuer on movements in Securities for the month ended 30 September 2024 Regulatory Filings	2024-10-03	English
VOLUNTARY ANNOUNCEMENT - GANNEX'S STRATEGIC PARTNER SAGIMET ANNOUNCES RECEIPT OF FDA BREAKTHROUGH THERAPY DESIGNATION FOR ASC40 (DENIFANSTAT) FOR TREATMENT OF BIOPSY-CONFIRMED F2/F3 MASH Regulatory Filings	2024-10-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024 Regulatory Filings	2024-10-02	English
Next Day Disclosure Return Regulatory Filings	2024-09-30	English
Interim Report 2024 Regulatory Filings	2024-09-27	English
Notification Letter and Reply Form to Registered Shareholders Regulatory Filings	2024-09-26	English
Notification Letter and Request Form to Non-registered Shareholder(s) Regulatory Filings	2024-09-26	English
INTERIM REPORT 2024 Regulatory Filings	2024-09-26	English
Next Day Disclosure Return Regulatory Filings	2024-09-26	English
Next Day Disclosure Return Regulatory Filings	2024-09-25	English
Next Day Disclosure Return Regulatory Filings	2024-09-24	English
ANNOUNCEMENT - CHANGE IN USE OF PROCEEDS Regulatory Filings	2024-09-23	English
VOLUNTARY ANNOUNCEMENT - ASCLETIS ENTERS THE OBESITY DRUG SPACE WITH ANNOUNCEMENT OF TWO ONGOING U.S. PHASE I CLINICAL TRIALS UTILIZING ITS SMALL MOLECULE GLP-1R AGONIST ASC30 FOR BOTH ONCE-MONTHLY SU Regulatory Filings	2024-09-17	English
Next Day Disclosure Return Regulatory Filings	2024-09-17	English
Next Day Disclosure Return Regulatory Filings	2024-09-16	English
Next Day Disclosure Return Regulatory Filings	2024-09-11	English
Next Day Disclosure Return Regulatory Filings	2024-09-09	English
Next Day Disclosure Return Regulatory Filings	2024-09-05	English
Monthly Return of Equity Issuer on movements in Securities for the month ended 31 August 2024 Regulatory Filings	2024-09-02	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024 Regulatory Filings	2024-09-02	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024 AND SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO 2023 ANNUAL REPORT Regulatory Filings	2024-08-30	English
ANNOUNCEMENT OF INTERIM RESULTS 2024 Regulatory Filings	2024-08-28	English
DATE OF BOARD MEETING Regulatory Filings	2024-08-16	English
PROFIT WARNING Regulatory Filings	2024-08-07	English
Monthly Return of Equity Issuer on movements in Securities for the month ended 31 July 2024 Regulatory Filings	2024-08-02	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024 Regulatory Filings	2024-08-02	English
Next Day Disclosure Return Regulatory Filings	2024-07-30	English
NOTICE OF BOARD MEETING Regulatory Filings	2024-07-30	English
Next Day Disclosure Return Regulatory Filings	2024-07-29	English
Next Day Disclosure Return Regulatory Filings	2024-07-26	English
Next Day Disclosure Return Regulatory Filings	2024-07-25	English
Next Day Disclosure Return Regulatory Filings	2024-07-24	English
Next Day Disclosure Return Regulatory Filings	2024-07-23	English
Next Day Disclosure Return Regulatory Filings	2024-07-22	English
Next Day Disclosure Return Regulatory Filings	2024-07-19	English
Next Day Disclosure Return Regulatory Filings	2024-07-18	English
Next Day Disclosure Return Regulatory Filings	2024-07-17	English
Next Day Disclosure Return Regulatory Filings	2024-07-15	English
Next Day Disclosure Return Regulatory Filings	2024-07-10	English
Next Day Disclosure Return Regulatory Filings	2024-07-04	English
Monthly Return of Equity Issuer on movements in Securities for the month ended 30 June 2024 Regulatory Filings	2024-07-02	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024 Regulatory Filings	2024-07-02	English
VOLUNTARY ANNOUNCEMENT - PROPOSED SHARE REPURCHASE UNDER THE REPURCHASE MANDATE Regulatory Filings	2024-07-02	English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 13 JUNE 2024 Regulatory Filings	2024-06-13	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 13 JUNE 2024 Regulatory Filings	2024-06-13	English
VOLUNTARY ANNOUNCEMENT - GANNEX ANNOUNCES POSTER PRESENTATION DESCRIBING POSITIVE INTERIM 12-WEEK RESULTS FROM ONGOING 52-WEEK PHASE II CLINICAL TRIAL OF ONCE-DAILY ASC41 IN PATIENTS WITH BIOPSY-CONFI Regulatory Filings	2024-06-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024 Regulatory Filings	2024-06-04	English
Monthly Return of Equity Issuer on movements in Securities for the month ended 31 May 2024 Regulatory Filings	2024-06-03	English
INSIDE INFORMATION INDUSTRY INVESTMENT PROMOTION PROJECT AGREEMENT Regulatory Filings	2024-05-23	English
SHARE OPTION SCHEME Regulatory Filings	2024-05-23	English
Notification Letter and Reply Form to Registered Shareholders Regulatory Filings	2024-05-23	English
Notification Letter and Request Form to Non-registered Shareholder(s) Regulatory Filings	2024-05-23	English
FORM OF PROXY FOR EXTRAORDINARY GENERAL MEETING (or any adjournment thereof) Regulatory Filings	2024-05-23	English
NOTICE OF EXTRAORDINARY GENERAL MEETING Regulatory Filings	2024-05-23	English
PROPOSED ADOPTION OF SHARE OPTION SCHEME AND NOTICE OF EXTRAORDINARY GENERAL MEETING Regulatory Filings	2024-05-23	English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON MAY 23, 2024 Regulatory Filings	2024-05-23	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024 Regulatory Filings	2024-05-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024 Regulatory Filings	2024-05-06	English
Monthly Return of Equity Issuer on movements in Securities for the month ended 30 April 2024 Regulatory Filings	2024-05-02	English
Form of Proxy for the 2024 Annual General Meeting Regulatory Filings	2024-04-26	English
Notice of 2024 Annual General Meeting Regulatory Filings	2024-04-26	English
Proposals for General Mandates to Issue Shares and Repurchase Shares, Re-Election of Retiring Directors and Notice of Annual General Meeting Regulatory Filings	2024-04-26	English
Annual Report 2023 Regulatory Filings	2024-04-26	English
GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES, RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING Regulatory Filings	2024-04-25	English
NOTICE OF ANNUAL GENERAL MEETING Regulatory Filings	2024-04-25	English
FORM OF PROXY FOR ANNUAL GENERAL MEETING (or any adjournment thereof) Regulatory Filings	2024-04-25	English
Annual Report 2023 Regulatory Filings	2024-04-25	English
Notification Letter and Request Form to Non-registered Holder(s) Regulatory Filings	2024-04-25	English
Notification Letter and Reply Form to Registered Shareholders Regulatory Filings	2024-04-25	English
Notification Letter to Non-Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications and Reply Form Regulatory Filings	2024-04-09	English
Notification Letter to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications and Reply Form Regulatory Filings	2024-04-09	English
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES STRATEGIC DECISIONS ON FXR AGONIST ASC42 Regulatory Filings	2024-04-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024 Regulatory Filings	2024-04-02	English
Monthly Return of Equity Issuer on movements in Securities for the month ended 31 March 2024 Regulatory Filings	2024-04-02	English
RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023 Regulatory Filings	2024-03-26	English
ANNUAL RESULTS OF ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023 Regulatory Filings	2024-03-25	English
DATE OF BOARD MEETING Regulatory Filings	2024-03-14	English
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES POSTER PRESENTATION OF PHASE II STUDY FINAL RESULTS OF FASN INHIBITOR ASC40 FOR TREATMENT OF ACNE AT 2024 AAD ANNUAL MEETING Regulatory Filings	2024-03-11	English
Next Day Disclosure Return Regulatory Filings	2024-03-05	English
Monthly Return of Equity Issuer on movements in Securities for the month ended 29 February 2024 Regulatory Filings	2024-03-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024 Regulatory Filings	2024-03-01	English
NOTICE OF BOARD MEETING Regulatory Filings	2024-02-23	English
Next Day Disclosure Return Regulatory Filings	2024-02-22	English
Next Day Disclosure Return Regulatory Filings	2024-02-21	English
Next Day Disclosure Return Regulatory Filings	2024-02-19	English
Next Day Disclosure Return Regulatory Filings	2024-02-16	English
Next Day Disclosure Return Regulatory Filings	2024-02-15	English
Next Day Disclosure Return Regulatory Filings	2024-02-14	English
Next Day Disclosure Return Regulatory Filings	2024-02-09	English
Next Day Disclosure Return Regulatory Filings	2024-02-08	English
Next Day Disclosure Return Regulatory Filings	2024-02-07	English
Next Day Disclosure Return Regulatory Filings	2024-02-06	English
Next Day Disclosure Return Regulatory Filings	2024-02-05	English
Next Day Disclosure Return Regulatory Filings	2024-02-02	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024 Regulatory Filings	2024-02-02	English
Monthly Return of Equity Issuer on movements in Securities for the month ended 31 January 2024 Regulatory Filings	2024-02-01	English
Next Day Disclosure Return Regulatory Filings	2024-02-01	English
Next Day Disclosure Return Regulatory Filings	2024-01-31	English
Next Day Disclosure Return Regulatory Filings	2024-01-30	English
SUPPLEMENTAL ANNOUNCEMENT DISCLOSEABLE TRANSACTION GRANTING OF LOAN Regulatory Filings	2024-01-29	English
Next Day Disclosure Return Regulatory Filings	2024-01-29	English
Next Day Disclosure Return Regulatory Filings	2024-01-26	English
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES DOSING OF THE FIRST PATIENT IN PHASE III CLINICAL TRIAL OF ASC40 (DENIFANSTAT) FOR TREATMENT OF ACNE Regulatory Filings	2024-01-24	English
DISCLOSEABLE TRANSACTION GRANTING OF LOAN Regulatory Filings	2024-01-23	English
Next Day Disclosure Return Regulatory Filings	2024-01-22	English
Next Day Disclosure Return Regulatory Filings	2024-01-19	English
Next Day Disclosure Return Regulatory Filings	2024-01-18	English
Next Day Disclosure Return Regulatory Filings	2024-01-17	English
Next Day Disclosure Return Regulatory Filings	2024-01-16	English
Next Day Disclosure Return Regulatory Filings	2024-01-15	English
Next Day Disclosure Return Regulatory Filings	2024-01-12	English
Next Day Disclosure Return Regulatory Filings	2024-01-11	English
Next Day Disclosure Return Regulatory Filings	2024-01-10	English
Next Day Disclosure Return Regulatory Filings	2024-01-09	English
Next Day Disclosure Return Regulatory Filings	2024-01-08	English
Next Day Disclosure Return Regulatory Filings	2024-01-05	English
Next Day Disclosure Return Regulatory Filings	2024-01-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023 Regulatory Filings	2024-01-04	English
GRANT OF SHARE OPTIONS Regulatory Filings	2024-01-03	English
VOLUNTARY ANNOUNCEMENT - GANNEX ANNOUNCES POSITIVE INTERIM RESULTS FROM 52-WEEK PHASE II CLINICAL TRIAL OF ONCE-DAILY ASC41 TABLET IN PATIENTS WITH BIOPSY-CONFIRMED NON-ALCOHOLIC STEATOHEPATITIS Regulatory Filings	2024-01-02	English
Monthly Return of Equity Issuer on movements in Securities for the month ended 31 December 2023 Regulatory Filings	2024-01-02	English

Filings by year

2026 22 filings
2025 159 filings
2024 184 filings
2023 178 filings
2022 127 filings
2021 160 filings
2020 98 filings
2019 74 filings
2018 63 filings
2017 33 filings
2016 31 filings
2015 30 filings
2014 27 filings
2013 29 filings
2012 41 filings
2011 29 filings
2010 27 filings
2009 23 filings
2008 16 filings
2007 23 filings
2006 18 filings
2005 19 filings
2004 18 filings
2003 13 filings
2002 8 filings
2001 7 filings
2000 8 filings
1999 5 filings